Double Medical Technology Inc (002901) — Capital Reinvestment Ratio

Latest as of September 2025: 0.15x

Double Medical Technology Inc (002901) has a Capital Reinvestment Ratio of 0.15x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥207.34 Million) in capital expenditures (CN¥30.36 Million). See Double Medical Technology Inc (002901) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.15x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥207.34 Million
CNY

Capital Expenditures

CN¥30.36 Million
CNY

Data as of

Sep 2025
Most recent filing

Double Medical Technology Inc Capital Reinvestment Ratio (2013–2025)

This chart tracks Double Medical Technology Inc's Capital Reinvestment Ratio across 13 annual periods.

Annual Capital Reinvestment Ratio for Double Medical Technology Inc (2013–2025)

Year-by-year Capital Reinvestment Ratio for Double Medical Technology Inc from 2013 to 2025. For live market cap and broader valuation context, see how much is Double Medical Technology Inc worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.16x CN¥831.34 Million CN¥133.51 Million ▼ -73.7%
2024 0.61x CN¥442.30 Million CN¥270.46 Million ▼ -85.2%
2023 4.14x CN¥73.89 Million CN¥305.72 Million ▲ +86.4%
2022 2.22x CN¥128.44 Million CN¥285.07 Million ▲ +535.6%
2021 0.35x CN¥673.26 Million CN¥235.11 Million ▲ +41.5%
2020 0.25x CN¥555.77 Million CN¥137.13 Million ▼ -66.5%
2019 0.74x CN¥433.88 Million CN¥319.29 Million ▲ +138.4%
2018 0.31x CN¥334.88 Million CN¥103.38 Million ▲ +158.4%
2017 0.12x CN¥308.70 Million CN¥36.89 Million ▼ -25.8%
2016 0.16x CN¥207.13 Million CN¥33.35 Million ▼ -74.0%
2015 0.62x CN¥123.44 Million CN¥76.53 Million ▲ +16.0%
2014 0.53x CN¥151.12 Million CN¥80.74 Million ▲ +93.2%
2013 0.28x CN¥106.51 Million CN¥29.46 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow